Insertion of c-MycintoIghInduces B-Cell and Plasma-Cell Neoplasms in Mice
- 15 February 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (4), 1306-1315
- https://doi.org/10.1158/0008-5472.can-04-0268
Abstract
We used gene targeting in mice to insert a His6-tagged mouse c-Myc cDNA, MycHis, head to head into the mouse immunoglobulin heavy-chain locus, Igh, just 5′ of the intronic enhancer, Eμ. The insertion of MycHis mimicked both the human t(8;14)(q24;q32) translocation that results in the activation of MYC in human endemic Burkitt lymphomas and the homologous mouse T(12;15) translocation that deregulates Myc in certain mouse plasmacytomas. Beginning at the age of 6 months, MycHis transgenic mice developed B-cell and plasma neoplasms, such as IgM+ lymphoblastic B-cell lymphomas, Bcl-6+ diffuse large B-cell lymphomas, and CD138+ plasmacytomas, with an overall incidence of 68% by 21 months. Molecular studies of lymphoblastic B-cell lymphoma, the most prevalent neoplasm (50% of all tumors), showed that the lymphomas were clonal, overexpressed MycHis, and exhibited the P2 to P1 promoter shift in Myc expression, a hallmark of MYC/Myc deregulation in human endemic Burkitt lymphoma and mouse plasmacytoma. Only 1 (6.3%) of 16 lymphoblastic B-cell lymphomas contained a BL-typical point mutation in the amino-terminal transactivation domain of MycHis, suggesting that most of these tumors are derived from naive, pregerminal center B cells. Twelve (46%) of 26 lymphoblastic B-cell lymphomas exhibited changes in the p19Arf-Mdm2-p53 tumor suppressor axis, an important pathway for Myc-dependent apoptosis. We conclude that MycHis insertion into Igh predictably induces B-cell and plasma-cell tumors in mice, providing a valuable mouse model for understanding the transformation-inducing consequences of the MYC/Myc-activating endemic Burkitt lymphoma t(8;14)/plasmacytoma T(12;15) translocation.Other Versions
This publication has 48 references indexed in Scilit:
- Persistence of the Epstein–Barr Virus and the Origins of Associated LymphomasThe New England Journal of Medicine, 2004
- Epstein-Barr virus nuclear antigen-1 and Myc cooperate in lymphomagenesisInternational Journal of Cancer, 2003
- Suppression of Myc-Induced Apoptosis in β Cells Exposes Multiple Oncogenic Properties of Myc and Triggers Carcinogenic ProgressionCell, 2002
- Topological Organization of the MYC/IGK Locus in Burkitt's Lymphoma Cells Assessed by Nuclear Halo PreparationsExperimental Cell Research, 2002
- The INK4a/ARF network in tumour suppressionNature Reviews Molecular Cell Biology, 2001
- Healthy mice with an altered c-myc gene: role of the 3′ untranslated region revisitedOncogene, 2001
- B‐cell commitment, development and selectionImmunological Reviews, 2000
- Rapid induction of B-cell lymphomas in mice carrying a human IgH/c-mycYACOncogene, 1997
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985